Skip to main content
. 2018 Jan 22;2018(1):CD012919. doi: 10.1002/14651858.CD012919
1 Randomized controlled trial/
2 Controlled clinical study/
3 Random$.ti,ab.
4 randomization/
5 intermethod comparison/
6 placebo.ti,ab.
7 (compare or compared or comparison).ti.
8 (open adj label).ti,ab.
9 ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab.
10 double blind procedure/
11 parallel group$1.ti,ab.
12 (crossover or cross over).ti,ab.
13 ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab.
14 (assigned or allocated).ti,ab.
15 (controlled adj7 (study or design or trial)).ti,ab.
16 (volunteer or volunteers).ti,ab.
17 trial.ti.
18 or/1‐17
19 exp breast/
20 exp breast disease/
21 (19 or 20) and exp neoplasm/
22 exp breast tumor/
23 exp breast cancer/
24 exp breast carcinoma/
25 (breast$ adj5 (neoplas$ or cancer$ or carcin$ or tumo$ or metasta$ or malig$)).ti,ab.
26 or/21‐25
27 exp cyclin dependent kinase inhibitor/
28 cyclin dependent kinase$ inhibit$.mp.
29 exp cyclin dependent kinase 4/
30 cyclin dependent kinase 4.mp.
31 exp cyclin dependent kinase 6/
32 cyclin dependent kinase 6.mp.
33 exp palbociclib/
34 palbociclib.mp.
35 exp ribociclib/
36 ribociclib.mp.
37 exp abemaciclib/
38 abemaciclib.mp.
39 or/27‐38
40 18 and 26 and 39
41 limit 40 to (human and (conference abstracts or embase))